水飞蓟素防治代谢综合征的作用机制研究进展
Research Progress on the Mechanism of Silymarin in Preventing and Treating Metabolic Syndrome
DOI: 10.12677/jcpm.2024.34293, PDF,    科研立项经费支持
作者: 张皓然, 李 娟, 杜丽坤*：黑龙江中医药大学附属第一医院内分泌二科，黑龙江 哈尔滨
关键词: 水飞蓟素；代谢综合征；药理靶点；作用机制；Silymarin； Metabolic Syndrome； Pharmacogical Target； Mechanism of Action
摘要: 目的：水飞蓟种子中含有大量的黄酮类化合物，主要为水飞蓟素。本文对水飞蓟素防治代谢综合征的作用机制以及研究进展进行综述。为研发以防治代谢综合征为主要作用的药品或保健药食提供科学依据。方法：查阅有关水飞蓟素防治代谢综合征的相关文献，并系统总结与梳理。结果：水飞蓟素具有调节血脂、降低血糖、抗炎、抗肿瘤、抗氧化、抗凝血、抗动脉粥样硬化等药理作用，可以改善氧化应激、改善胰岛素抵抗(IR)、肥胖、保护血管内皮、改善肠道菌群、抑制血小板聚集、抑制炎症因子表达。结论：水飞蓟素作为无肝脏不良反应的保肝降脂药，具有抗氧化、抗炎、防治代谢综合征等功能，有望成为新型有效的保健食品。
Abstract: Objective: The seeds of silymarin contain a large amount of flavonoids, mainly silymarin. This article reviews the mechanism of action and research progress of silymarin in the prevention and treatment of metabolic syndrome to provide a scientific basis for the development of drugs or health supplements with the main function of preventing and treating metabolic syndrome. Method: We review relevant literature on the prevention and treatment of metabolic syndrome with silymarin, and systematically summarize and sort it out. Results: Silymarin has the pharmacological effects of regulating blood lipids, lowering blood sugar, anti-inflammatory, anti-tumor, antioxidant, anticoagulant, anti atherosclerosis, etc. It can improve oxidative stress, improve insulin resistance (IR), obesity, regulate lipid metabolism, protect vascular endothelium, improve intestinal flora, inhibit platelet aggregation, and inhibit the expression of inflammatory factors. Conclusion: Silymarin, as a liver protective and lipid-lowering drug without adverse liver reactions, has functions such as antioxidant, anti-inflammatory, and prevention and treatment of metabolic syndrome, and is expected to become a new and effective health food.
文章引用：张皓然, 李娟, 杜丽坤. 水飞蓟素防治代谢综合征的作用机制研究进展[J]. 临床个性化医学, 2024, 3(4): 2077-2083. https://doi.org/10.12677/jcpm.2024.34293

参考文献

[1] He, L., Zhou, X., Huang, N., Li, H., Tian, J., Li, T., et al. (2017) AMPK Regulation of Glucose, Lipid and Protein Metabolism: Mechanisms and Nutritional Significance. Current Protein & Peptide Science, 18, 562-570. [Google Scholar] [CrossRef] [PubMed]
[2] Wang, S.Z., Min, W.U., Chen, K.J., et al. (2019) Hawthorn Extract Al-Leviates Atherosclerosis through Regulating Inflammation and Apotosis Related Factors: An Experimental Study. Chinese Journal of Integrative Medicine, 25, 108-115.
[3] Shatoor, A.S. and Al Humayed, S. (2019) The Protective Effect of Crataegus Aronia against High-Fat Diet-Induced Vascular Inflammation in Rats Entails Inhibition of the NLRP-3 Inflammasome Pathway. Cardiovascular Toxicology, 20, 82-99. [Google Scholar] [CrossRef] [PubMed]
[4] Li, L., Gao, P., Song, S., Yuan, Y., Liu, C., Huang, X., et al. (2015) Monoterpenes and Flavones from the Leaves of Crataegus Pinnatifida with Anticoagulant Activities. Journal of Functional Foods, 12, 237-245. [Google Scholar] [CrossRef] 
[5] 祝新茗, 李沐阳, 王桂芹, 黄酮类化合物在水产动物营养上的研究进展[J]. 饲料工业, 2021, 42(16): 26-31.
[6] Zhou, C., Huang, X., Gao, P., Li, F., Li, D., Li, L., et al. (2013) Two New Compounds from Crataegus Pinnatifida and Their Antithrombotic Activities. Journal of Asian Natural Products Research, 16, 169-174. [Google Scholar] [CrossRef] [PubMed]
[7] Anuradha, R., Saraswati, M., Kumar, K.G. and Rani, S.H. (2014) Apoptosis of Beta Cells in Diabetes Mellitus. DNA and Cell Biology, 33, 743-748. [Google Scholar] [CrossRef] [PubMed]
[8] Oh, Y.S., Bae, G.D., Baek, D.J., Park, E. and Jun, H. (2018) Fatty Acid-Induced Lipotoxicity in Pancreatic Beta-Cells during Development of Type 2 Diabetes. Frontiers in Endocrinology, 9, Article No. 384. [Google Scholar] [CrossRef] [PubMed]
[9] Sun, Y., Yang, J., Liu, W., Yao, G., Xu, F., Hayashi, T., et al. (2019) Attenuating Effect of Silibinin on Palmitic Acid-Induced Apoptosis and Mitochondrial Dysfunction in Pancreatic Β-Cells Is Mediated by Estrogen Receptor Alpha. Molecular and Cellular Biochemistry, 460, 81-92. [Google Scholar] [CrossRef] [PubMed]
[10] Mi, X., Choi, H.S., Perumalsamy, H., Shanmugam, R., Thangavelu, L., Balusamy, S.R., et al. (2022) Biosynthesis and Cytotoxic Effect of Silymarin-Functionalized Selenium Nanoparticles Induced Autophagy Mediated Cellular Apoptosis via Downregulation of PI3K/Akt/mTOR Pathway in Gastric Cancer. Phytomedicine, 99, Article 154014. [Google Scholar] [CrossRef] [PubMed]
[11] van der Pol, A., van Gilst, W.H., Voors, A.A. and van der Meer, P. (2018) Treating Oxidative Stress in Heart Failure: Past, Present and Future. European Journal of Heart Failure, 21, 425-435. [Google Scholar] [CrossRef] [PubMed]
[12] Muthumani, M. and Prabu, S.M. (2013) Silibinin Potentially Attenuates Arsenic-Induced Oxidative Stress Mediated Cardiotoxicity and Dyslipidemia in Rats. Cardiovascular Toxicology, 14, 83-97. [Google Scholar] [CrossRef] [PubMed]
[13] Kim, S., Kim, K., Yu, S., Seo, Y., Chun, S., Yu, H., et al. (2016) Silibinin Induces Mitochondrial Nox4-Mediated Endoplasmic Reticulum Stress Response and Its Subsequent Apoptosis. BMC Cancer, 16, Article No. 452. [Google Scholar] [CrossRef] [PubMed]
[14] Fallah, M., Davoodvandi, A., Nikmanzar, S., Aghili, S., Mirazimi, S.M.A., Aschner, M., et al. (2021) Silymarin (Milk Thistle Extract) as a Therapeutic Agent in Gastrointestinal Cancer. Biomedicine & Pharmacotherapy, 142, Article 112024. [Google Scholar] [CrossRef] [PubMed]
[15] Kim, S., Choo, G., Yoo, E., Woo, J., Han, S., Lee, J., et al. (2019) Silymarin Induces Inhibition of Growth and Apoptosis through Modulation of the MAPK Signaling Pathway in AGS Human Gastric Cancer Cells. Oncology Reports, 42, 1904-1914. [Google Scholar] [CrossRef] [PubMed]
[16] Wu, T., Liu, W., Guo, W. and Zhu, X. (2016) Silymarin Suppressed Lung Cancer Growth in Mice via Inhibiting Myeloid-Derived Suppressor Cells. Biomedicine & Pharmacotherapy, 81, 460-467. [Google Scholar] [CrossRef] [PubMed]
[17] Yassin, N.Y.S., AbouZid, S.F., El-Kalaawy, A.M., Ali, T.M., Almehmadi, M.M. and Ahmed, O.M. (2022) Silybum Marianum Total Extract, Silymarin and Silibinin Abate Hepatocarcinogenesis and Hepatocellular Carcinoma Growth via Modulation of the HGF/c-Met, WNT/β-Catenin, and PI3K/Akt/mTOR Signaling Pathways. Biomedicine & Pharmacotherapy, 145, Article 112409. [Google Scholar] [CrossRef] [PubMed]
[18] Tönnies, E. and Trushina, E. (2017) Oxidative Stress, Synaptic Dysfunction, and Alzheimer’s Disease. Journal of Alzheimer’s Disease, 57, 1105-1121. [Google Scholar] [CrossRef] [PubMed]
[19] Lee, J., Jo, D., Park, D., Chung, H.Y. and Mattson, M.P. (2014) Adaptive Cellular Stress Pathways as Therapeutic Targets of Dietary Phytochemicals: Focus on the Nervous System. Pharmacological Reviews, 66, 815-868. [Google Scholar] [CrossRef] [PubMed]
[20] Shen, L., Liu, L., Li, X. and Ji, H. (2019) Regulation of Gut Microbiota in Alzheimer’s Disease Mice by Silibinin and Silymarin and Their Pharmacological Implications. Applied Microbiology and Biotechnology, 103, 7141-7149. [Google Scholar] [CrossRef] [PubMed]
[21] Tong, T.C., Hernandez, M., Richardson, W.H., Betten, D.P., Favata, M., Riffenburgh, R.H., et al. (2007) Comparative Treatment of Α-Amanitin Poisoning with N-Acetylcysteine, Benzylpenicillin, Cimetidine, Thioctic Acid, and Silybin in a Murine Model. Annals of Emergency Medicine, 50, 282-288. [Google Scholar] [CrossRef] [PubMed]
[22] Lalani, S., Masomian, M. and Poh, C.L. (2021) Functional Insights into Silymarin as an Antiviral Agent against Enterovirus A71 (EV-A71). International Journal of Molecular Sciences, 22, Article No. 8757. [Google Scholar] [CrossRef] [PubMed]
[23] Nguyen, T.T., Trinh, N., Tran, H.N., Tran, H.T., Le, P.Q., Ngo, D., et al. (2021) Improving Silymarin Oral Bioavailability Using Silica-Installed Redox Nanoparticle to Suppress Inflammatory Bowel Disease. Journal of Controlled Release, 331, 515-524. [Google Scholar] [CrossRef] [PubMed]
[24] Paul, S., Arya, A., Gangwar, A., Bhargava, K. and Ahmad, Y. (2016) Size Restricted Silymarin Suspension Evokes Integrated Adaptive Response against Acute Hypoxia Exposure in Rat Lung. Free Radical Biology and Medicine, 96, 139-151. [Google Scholar] [CrossRef] [PubMed]
[25] Vostálová, J., Tinková, E., Biedermann, D., Kosina, P., Ulrichová, J. and Rajnochová Svobodová, A. (2019) Skin Protective Activity of Silymarin and Its Flavonolignans. Molecules, 24, Article No. 1022. [Google Scholar] [CrossRef] [PubMed]
[26] Pientaweeratch, S., Panapisal, V. and Tansirikongkol, A. (2016) Antioxidant, Anti-Collagenase and Anti-Elastase Activities of Phyllanthus Emblica, Manilkara Zapota and Silymarin: An in Vitro Comparative Study for Anti-Aging Applications. Pharmaceutical Biology, 54, 1865-1872. [Google Scholar] [CrossRef] [PubMed]
[27] Yang, J., Sun, Y., Xu, F., Liu, W., Mai, Y., Hayashi, T., et al. (2018) Silibinin Ameliorates Amylin-Induced Pancreatic Β-Cell Apoptosis Partly via Upregulation of GLP-1R/PKA Pathway. Molecular and Cellular Biochemistry, 452, 83-94. [Google Scholar] [CrossRef] [PubMed]
[28] Liu, P., Cui, L., Liu, B., Liu, W., Hayashi, T., Mizuno, K., et al. (2020) Silibinin Ameliorates STZ-Induced Impairment of Memory and Learning by Up-Regulating Insulin Signaling Pathway and Attenuating Apoptosis. Physiology & Behavior, 213, Article 112689. [Google Scholar] [CrossRef] [PubMed]
[29] Wang, H., Li, Y., Li, A., Yan, F., Li, Z., Liu, Z., et al. (2017) Erratum to: Forskolin Induces Hyperphosphorylation of Tau Accompanied by Cell Cycle Reactivation in Primary Hippocampal Neurons. Molecular Neurobiology, 55, 707-708. [Google Scholar] [CrossRef] [PubMed]
[30] Bartoli, M., Abouhish, H., Jadeja, R., et al. (2022) Anti-Senescence Properties of the Flavone Silymarin in the Diabetic Retina Involve Direct Inhibition of the Histone Deacetylase 6 (HDAC6). Investigative Ophthalmology & Visual Science, 63, Article No. 4117.
[31] Peng, H., Sun, Y., Hao, J., Lu, C., Bi, M. and Song, E. (2019) Neuroprotective Effects of Overexpressed Microrna-200a on Activation of Glaucoma-Related Retinal Glial Cells and Apoptosis of Ganglion Cells via Downregulating Fgf7-Mediated MAPK Signaling Pathway. Cellular Signalling, 54, 179-190. [Google Scholar] [CrossRef] [PubMed]
[32] Shen, Y., Zhao, H., Wang, Z., Guan, W., Kang, X., Tai, X., et al. (2019) Silibinin Declines Blue Light-Induced Apoptosis and Inflammation through MEK/ERK/CREB of Retinal Ganglion Cells. Artificial Cells, Nanomedicine, and Biotechnology, 47, 4059-4065. [Google Scholar] [CrossRef] [PubMed]
[33] Abrass, C.K. (1995) Diabetic Nephropathy. Mechanisms of Mesangial Matrix Expansion. Western Journal of Medicine, 162, 318-321.
[34] 赵欣, 戚慧贞. 水飞蓟素的药理作用[J]. 山东医药, 2006, 46(2): 57.
[35] 韦良开, 白心亮, 李瑞, 等. 水飞蓟的生物学功能及其在畜牧业中的应用研究进展[J]. 动物营养学报, 2021, 33(9): 4882-4889.
[36] 苟庚午, 蒋明, 文华, 等. 饲料中添加水飞蓟素对吉富罗非鱼生长性能、肝脏脂肪代谢酶和抗氧化能力的影响[J]. 水产学报, 2016, 40(9): 1309-1320.
[37] 刘明, 刘熙鹏, 李淳, 等. 水飞蓟素通过调控miR-124-3p/WEE1轴影响胶质瘤细胞恶性生长的机制研究[J]. 中国医科大学学报, 2024, 53(2): 142-148.
[38] 余小虎, 朱金水, 邱夏地, 等. 水飞蓟素联合二甲双胍治疗肥胖型非酒精性脂肪肝的临床研究[J]. 实用肝脏病杂志, 2005, 8(5): 269-271.
[39] 梁梦秋, 李磊, 孟艳秋, 等. 水飞蓟宾防治糖尿病及其并发症的作用机制研究进展[J]. 中国药房, 2023, 34(7): 887-891.
[40] 史向国, 钟大放, 张逸凡, 等. 反相高效液相色谱法测定大鼠血浆中水飞蓟宾的浓度[J]. 沈阳药科大学学报, 2001, 18(2): 113-115.
[41] 翟硕, 李娜, 陈蓓宁, 等. 水飞蓟在治疗慢性肝炎中的研究进展[J]. 中国临床药理学与治疗学, 2019, 24(5): 573-579.
[42] Suguro, R., Pang, X., Yuan, Z., Chen, S., Zhu, Y. and Xie, Y. (2020) Combinational Applicaton of Silybin and Tangeretin Attenuates the Progression of Non-Alcoholic Steatohepatitis (NASH) in Mice via Modulating Lipid Metabolism. Pharmacological Research, 151, Article 104519. [Google Scholar] [CrossRef] [PubMed]
[43] Federico, A., Dallio, M., Masarone, M., Gravina, A.G., Di Sarno, R., Tuccillo, C., et al. (2019) Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients. Oxidative Medicine and Cellular Longevity, 2019, 1-12. [Google Scholar] [CrossRef] [PubMed]
[44] Grasselli, E., Baldini, F., Vecchione, G., Oliveira, P., Sardo, V., Voci, A., et al. (2019) Excess Fructose and Fatty Acids Trigger a Model of Non-Alcoholic Fatty Liver Disease Progression in Vitro: Protective Effect of the Flavonoid Silybin. International Journal of Molecular Medicine, 44, 705-712. [Google Scholar] [CrossRef] [PubMed]